| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.8 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.8 |